2017 Fiscal Year Final Research Report
The molecular mechanism of drug induced mitochondrial dysfunction focused on mitochondrial quality control system
| Project/Area Number |
15K08226
|
|---|
| Research Category |
Grant-in-Aid for Scientific Research (C)
|
| Allocation Type | Multi-year Fund |
|---|
| Section | 一般 |
|---|
| Research Field |
General pharmacology
|
|---|
| Research Institution | Tohoku University |
|---|
Principal Investigator |
|
|---|
| Co-Investigator(Kenkyū-buntansha) |
佐藤 岳哉 東北大学, 医学系研究科, 准教授 (10312696)
久志本 成樹 東北大学, 医学系研究科, 教授 (50195434)
斎藤 将樹 東北大学, 医学系研究科, 助教 (50400271)
柳澤 輝行 東北福祉大学, 健康科学部, 教授 (90133941)
|
|---|
| Project Period (FY) |
2015-04-01 – 2018-03-31
|
| Keywords | ミトコンドリア品質管理機構 / ミトコンドリアダイナミクス / 毒性薬理 / 活性酸素種 / AZT |
|---|
| Outline of Final Research Achievements |
We established a cell model of rat embryonic myoblasts in which azidothymidine triphosphate (AZT-TP), active metabolites of AZT, that is anti-HIV (human immunodeficiency virus) drug accumulates in a short time. Using this cell model, it was found that lethal cardiac dysfunction due to long-term administration of AZT is caused by accumulation of AZT-TP. Furthermore, as a detailed mechanism of cytotoxicity, accumulation of AZT-TP causes impairment of the mitochondrial quality control system, damage of mitochondrial electron transport chain and increasing reactive oxygen species (ROS) produciton in the cell, that induce apoptosis and cell death.
|
| Free Research Field |
救急医学
|
